Laboratory Corporation of America Holdings (LH) Balance Sheet

NYSE: LHAssets, liabilities, debt and equity over 10 years.

LH balance sheet, 2025

December 31, 2025 · U.S. dollars

$18.39B assets = $9.76B liabilities + $8.64B equity

What it owns$18.39BCash & ST investments: $532.3M (2.9%)Receivables: $2.26B (12.3%)Receivables$2.26B · 12%Inventory: $534.7M (2.9%)Other current: $692.8M (3.8%)PP&E: $3.08B (16.8%)PP&E$3.08B · 17%Goodwill & intangibles: $10.39B (56.5%)Goodwill & intangibles$10.39B · 56%LT investments: $153.9M (0.8%)Other non-current: $751.3M (4.1%)=How it is financed$18.39BCurrent liabilities: $2.82B (15.4%)Current liabilities$2.82B · 15%Long-term debt: $5.15B (28.0%)Long-term debt$5.15B · 28%Other LT liabilities: $1.78B (9.7%)$1.78BShareholders’ equity: $8.64B (47.0%)Shareholders’ equity$8.64B · 47%

Both columns are drawn to the same scale: what LH owns equals what it owes plus shareholders’ equity. Hover a block for its value.

LH financial health

Current ratio1.42
Adequate · current assets cover current liabilities 1.42×
Debt / equity0.84
Moderate leverage · $0.84 of debt for each $1 of equity
Equity / assets46.9%
Equity-funded · of assets funded by shareholders
Cash / debt7.4%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles56.5%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

LH balance sheet trends, 2016–2025

Laboratory Corporation of America Holdings balance sheet trends
MetricTrendThenLatestChange
Total assets$14.25B2016$18.39B2025+2.9%/yr
Total liabilities$8.73B2016$9.76B2025+1.2%/yr
Shareholders’ equity$5.51B2016$8.62B2025+5.1%/yr
Cash & short-term investments$433.6M2016$532.3M2025+2.3%/yr
Total debt$5.85B2016$7.20B2025+2.3%/yr
Net cash (debt)−$5.42B2016−$6.67B2025−$1.3B
Working capital$651.1M2016$1.20B2025+$545.9M
Book value per share$52.792016$102.862025+7.7%/yr
Current ratio1.3620161.422025+0.07
Debt / equity1.0620160.842025−0.23
Shares outstanding104.3M201683.8M2025−2.4%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

LH assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

LH liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

LH debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

LH balance sheet

Laboratory Corporation of America Holdings annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$532.3M$1.52B$536.8M$320.6M$1.47B$1.32B$337.5M$426.8M$316.7M$433.6M
Cash & equivalents$532.3M$1.52B$536.8M$320.6M$1.47B$1.32B$337.5M$426.8M$316.6M$433.6M
Short-term investments————$10.9M$73.0M$9.1M—$0$0
Receivables$2.26B$2.10B$2.10B$2.00B$2.98B$3.02B$2.03B$1.86B$1.85B$1.52B
Inventory$534.7M$493.2M$474.6M$470.6M$401.4M$423.2M$244.7M$237.3M$227.6M$205.2M
Other current assets$692.8M$697.6M$655.3M$1.84B$478.1M$364.8M$373.7M$309.0M$290.8M$321.2M
Total current assets$4.02B$4.81B$3.77B$4.62B$5.33B$5.13B$2.98B$2.84B$2.68B$2.48B
Property, plant & equipment (net)$3.08B$3.05B$2.91B$2.79B$2.82B$2.73B$2.61B$1.78B$1.75B$1.72B
Goodwill & intangible assets$10.39B$9.86B$9.48B$9.25B$11.69B$11.71B$11.90B$11.27B$11.87B$9.82B
Long-term investments$153.9M$16.3M$26.9M$65.7M$60.9M$73.5M$84.9M$60.5M$58.4M$57.6M
Other non-current assets$751.3M$652.2M$536.5M$3.42B$484.2M$430.6M$444.2M$233.3M$207.3M$167.2M
Total assets$18.39B$18.38B$16.73B$20.16B$20.39B$20.07B$18.02B$16.19B$16.57B$14.25B
Liabilities
Accounts payable$840.8M$875.8M$827.5M$852.2M$621.3M$638.9M$632.3M$634.6M$573.9M$508.4M
Short-term debt$695.8M$1.19B$1.17B$471.1M$199.0M$575.4M$630.1M$17.9M$417.5M$549.5M
Deferred revenue$439.1M$392.2M$421.7M$310.6M$558.5M$506.5M$451.0M$356.4M$380.8M$176.0M
Total current liabilities$2.82B$3.33B$3.23B$3.08B$2.78B$3.08B$2.66B$1.88B$2.19B$1.83B
Long-term debt$5.15B$5.41B$4.13B$5.12B$5.50B$5.50B$5.88B$6.04B$6.34B$5.30B
Lease obligations$941.3M$941.3M$899.7M$954.8M$924.6M$960.7M$902.6M$58.9M$66.1M$71.8M
Other long-term liabilities$1.78B$1.58B$1.48B$1.84B$1.81B$2.03B$1.92B$1.27B$1.32B$1.60B
Total liabilities$9.76B$10.31B$8.83B$10.04B$10.09B$10.61B$10.46B$9.19B$9.85B$8.73B
Shareholders' equity
Common stock & paid-in capital$7.5M$7.6M$7.7M$8.1M$8.5M$9.0M$9.0M$11.7M$12.0M$12.1M
Retained earnings (deficit)$8.64B$8.30B$7.89B$10.58B$10.46B$9.48B$7.90B$7.08B$6.22B$4.96B
Treasury stock———————−$1.11B−$1.06B−$1.01B
Accumulated other comprehensive income−$27.6M−$261.6M−$59.3M−$493.2M−$192.0M−$161.9M−$372.4M−$463.1M−$335.7M−$581.1M
Minority interest$16.9M$14.3M$15.5M$18.9M$20.6M——$19.1M$20.8M$15.2M
Total shareholders' equity$8.62B$8.05B$7.88B$10.10B$10.27B$9.44B$7.57B$6.97B$6.80B$5.51B
Key figures
Total debt$7.20B$7.27B$5.95B$6.25B$6.34B$6.76B$7.11B$6.06B$6.76B$5.85B
Net cash (debt)−$6.67B−$5.75B−$5.42B−$5.93B−$4.87B−$5.44B−$6.77B−$5.63B−$6.45B−$5.42B
Working capital$1.20B$1.48B$540.2M$1.55B$2.55B$2.05B$325.4M$956.5M$496.9M$651.1M
Tangible book value−$1.77B−$1.81B−$1.61B$850.0M−$1.42B−$2.28B−$4.33B−$4.30B−$5.07B−$4.32B
Book value per share$102.86$95.41$89.90$110.22$105.37$96.29$76.74$67.95$65.49$52.79
Shares outstanding83.8M84.4M87.6M91.6M97.5M98.0M98.6M102.6M103.9M104.3M
Current ratio1.421.441.171.501.921.661.121.511.231.36
Quick ratio0.991.090.820.751.601.410.891.220.991.07
Debt / equity0.840.900.760.620.620.720.940.870.991.06
Equity / assets46.9%43.8%47.1%50.1%50.4%47.0%42.0%43.1%41.1%38.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.

LH financial position

At the end of fiscal 2025 (December 31, 2025), Labcorp had total assets of $18.4 billion (up 0.1% from a year earlier), total liabilities of $9.8 billion and shareholders' equity of $8.6 billion. It held $532.3 million in cash and short-term investments against $7.2 billion of debt, net debt of $6.7 billion. Its current ratio was 1.42. In the latest quarter (ended June 30, 2026) total assets were $18.5 billion and equity $8.6 billion.

Related: LH income statement, LH cash flow statement, LH key metrics. See the LH stock overview for the latest quote and news.

LH balance sheet FAQ

What are Labcorp's total assets?

Labcorp reported total assets of $18.4 billion at the end of fiscal 2025 (December 31, 2025), compared with $18.4 billion a year earlier.

How much debt does Labcorp have?

Labcorp had $7.2 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.84.

How much cash does Labcorp have?

Labcorp held $532.3 million in cash and short-term investments at the end of fiscal 2025; with $7.2 billion of debt that is net debt of $6.7 billion.

What is Labcorp's book value?

Labcorp's shareholders' equity (book value) was $8.6 billion at the end of fiscal 2025, or $102.86 per share.

What is Labcorp's current ratio?

Labcorp had current assets of $4.0 billion and current liabilities of $2.8 billion, a current ratio of 1.42 (it can cover its short-term obligations).

How much goodwill does Labcorp have?

Labcorp carried $10.4 billion of goodwill and intangible assets, 56.5% of total assets, at the end of fiscal 2025.

Diagnostics & Research: balance sheet